The drugmaker expects the regulator to remove Wegovy and Ozempic from its shortage list, blocking other companies from ...
While popular drugs like Ozempic and Wegovy are only available as injections, drugmaker Novo Nordisk is working on a more ...
Nearly 2 in 3 people without diabetes quit popular weight loss drugs such as Ozempic or Victoza within one year, according to ...
Investors are upset at a lack of clarity over the results of Wegovy successor CagriSema after trials published in December.
Novo Nordisk - which manufactures Wegovy, Ozempic and Saxenda - misreported, under-reported or did not disclose funding it ...
Novo Nordisk's stock (NVO) rose more than 8% in Friday trading ... similar to the company's blockbuster weight-loss ...
While it may seem strange that politics could impact the price of popular weight loss drugs, it is a definite possibility.
Ozempic and Wegovy maker Novo Nordisk quieted Wall Street’s concerns with its fourth-quarter results and 2025 outlook.
Wegovy maker Novo Nordisk on Wednesday forecast slower sales growth for 2025 than 2024, a blow that is likely to deepen ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback